Keywords
Lyme disease
tick-borne encephalitis
epidemiology
clinical symptoms
diagnostics
prevention
treatment
How to Cite
Abstract
Tick-borne diseases constitute a highly significant and continuously increasing health problem in Poland and Europe. The aim of the study is to discuss the most common infections caused by Borrelia burgdorferi s.l. and tick-borne encephalitis viruses, which are the most frequently reported tick-borne diseases in humans in European countries. The analysis included information on the nature of the etiological agent, clinical symptoms, diagnostic methods, treatment, and epidemiology of the mentioned diseases, collected based on current medical publications available in scientific databases. The study illustrates the scale of the problem and also draws attention to proper prophylaxis and appropriately selected diagnostics for patients with symptoms of infectious diseases.
References
NowakChmura M., Siuda K.: Ticks of Poland. Review of contemporary issues and latest research. Ann Parasitol 2012; 58(3): 125–155.
Kmieciak W., Ciszewski M., Szewczyk E.M.: Choroby odkleszczowe w Polsce – występowanie i trudności diagnostyczne. Medycyna Pracy 2016; 67(1): 73–87.
Barbour A.G., Benach J.L.: Discovery of the Lyme disease agent. mBio 2019; 10(5). doi: 10.1128/mBio.0216619.
Kean W.F.: The musculoskeletal abnormalities of the Simi- laun Iceman (“ÖTZI”): Clues to chronic pain and possible treatments. Inflammopharmacology 2013; 21(1): 11–20. doi: 10.1007/s1078701201535.
EstradaPeña A., Cutler S., Potkonjak A. i in.: An updated metaanalysis of the distribution and prevalence of Borrelia burgdorferi s.l. in ticks in Europe. Int J Health Geogr 2018; 17: 41. doi: 10.1186/s1294201801637.
Margos G., Vollmer S.A., Ogden N.H. i in.: Population genetics, taxonomy, phylogeny and evolution of Borrelia burg- dorferi sensu lato. Infect Genet Evol 2011; 11(7): 1545–1563. doi: 10.1016/j.meegid.2011.07.022.
Rudenko N., Golovchenko M., Ruzek D. i in.: Molecular detection of Borrelia bissettii DNA in serum samples from patients in the Czech Republic with suspected borreliosis. FEMS Microbiol Lett 2009; 292(2): 274–281. doi: 10.1111/j. 15746968.2009.01498.x.
Stanek G., Reiter M.: The expanding Lyme Borrelia complex – clinical significance of genomic species? Clin Microbiol Infect 2011; 17(4):487–493. doi: 10.1111/j. 14690691.2011.03492.x.
Da Franca I., Santos L., Mesquita T. i in.: Lyme borreliosis in Portugal caused by Borrelia lusitaniae? Clinical report on the first patient with a positive skin isolate. Wien Klin Wochenschr 2005; 117(11–12): 429–432. doi: 10.1007/s00508005 0386z.
Fingerle V., SchulteSpechtel U.C., RuzicSabljic E. i in.: Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. Nov. Int J Med Microbiol 2008; 298(3–4): 279–290. doi: 10.1016/j. ijmm.2007.05.002.
Pakanen V.M., Sormunen J.J., Sippola E. i in.: Questing abundance of adult taiga ticks Ixodes persulcatus and their Borrelia prevalence at the northwestern part of their distribution. Parasit Vectors 2020; 13: 384. doi: 10.1186/s13071 02004259z.
Wilson K.D., Elston D.M.: What’s eating you? Ixodes tick and related diseases, part 1: life cycle, local reactions, and lyme disease. Cutis 2018; 101(3): 187–190.
Patrican L.A.: Absence of Lyme disease spirochetes in larval progeny of naturally infected Ixodes scapularis (Acari:Ixodi- dae) fed on dogs. J Med Entomol 1997; 34(1): 52–55. doi: 10.1093/jmedent/34.1.52.
Craine N.G., Nuttall P.A., Marriott A.C. i in.: Role of grey squirrels and pheasants in the transmission of Borrelia burgdorferi sensu lato, the Lyme disease spirochaete, in the U.K. Folia Parasitologica (Praha) 1997; 44(2): 155–160.
Hofmeester T., Coipan E.C., van Wieren S.E. i in.: Few vertebrate species dominate the Borrelia burgdorferi s.l. Life cycle. Environ Res Lett 2016; 11(4): 043001. doi: 10.1088/1748 9326/11/4/043001.
Majerová K., Honig V., Houda M. i in.: Hedgehogs, squirrels, and blackbirds as sentinel hosts for active surveillance of Borrelia miyamotoi and Borrelia burgdorferi complex in urban and rural environments. Microorganisms 2020; 8(12): 1908. doi: 10.3390/microorganisms 8121908.
Obiegała, A., Król N., Oltersdorf C. i in.: The enzootic lifecycle of Borrelia burgdorferi (sensu lato) and tickborne rickettsiae: an epidemiological study on wildliving small mammals and their ticks from Saxony, Germany. Parasit Vectors 2017; 10: 115. doi: 10.1186/s1307101720534.
Mysterud A., Heylen D.J.A., Matthysen E. i in.: Lyme neuroborreliosis and bird populations in northern Europe. Proc Biol Sci 2019; 286(1903): 20190759. doi: 10.1098/ rspb.2019.0759.
Díaz P., Remesar S., Venzal J.M. i in.: Occurrence of Borrelia and Borreliella species in Ixodes ricinus collected from roe deer in northwestern Spain. Med Vet Entomol 2019; 33(3): 427–430. doi: 10.1111/mve.12364.
Hofmeester T.R., Krawczyk A., Docters van Leeuwen A. i in.: Role of mustelids in the lifecycle of ixodid ticks and transmission cycles of four tickborne pathogens. Parasit Vectors 2018; 11(600): 1–13. doi: 10.1186/s1307101831268.
MendozaRoldan J A., Colella V., Lia R.P. i in.: Borrelia burgdorferi (sensu lato) in ectoparasites and reptiles in southern Italy. Parasites & Vectors 2019; 12(1): 35. doi: 10.1186/ s13071-019-3286-1.
Tilly K., Rosa P.A., Stewart P.E.: Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am 2008; 22(2): 217–234. doi: 10.1016/j.idc.2007.12.013.
Eisen L.: Pathogen transmission in relation to duration of attachment by Ixodes scapularis ticks. Ticks Tick Borne Dis 2018; 9(3): 535–542. doi: 10.1016/j.ttbdis.2018.01.002.
Cull B., Pietzsch M.E., Gillingham E.L. i in.: Seasonality and anatomical location of human tick bites in the United Kingdom. Zoonoses Public Health 2020; 67(2): 112–121. doi: 10.1111/zph.12659.
Littman M.P., Gerber B., Goldstein R.E. i in.: ACVIM consensus update on Lyme borreliosis in dogs and cats. J Vet Intern Med 2018; 32(3): 887–903. doi: 10.1111/jvim.15085.
Mead P.: Epidemiology of Lyme disease. Infect Dis Clin North Am, 2022; 36(3):495521. doi: 10.1016/j.idc.2022.03.004.
Vu Hai V., Almeras L., Socolovschi C. i in.: Monitoring human tickborne disease risk and tick bite exposure in Europe: available tools and promising future methods. Ticks Tick Borne Dis 2014; 5(6):607–619. doi: 10.1016/j.ttbdis.2014.07.022.
Semenza J.C.; Suk J.E.: Vectorborne diseases and climate change: A European perspective. FEMS Microbiol Lett 2018; 365(2): fnx244. doi: 10.1093/femsle/fnx244.
Jaenson T.G., Jaenson D.G.E., Eisen L. i in.: Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors 2012; 5: 8. doi: 10.1186/1756330558.
Czarkowski M.P., Wielgosz U.: Choroby zakaźne i zatrucia w Polsce w 2023 roku. Warszawa: Narodowy Instytut Zdrowia Publicznego Państwowy Zakład Higieny – Państwowy Instytut Badawczy, Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Główny Inspektorat Sanitarny, Departament Przeciwepidemiczny i Ochrony Sanitarnej Granic; 2024. 1–176.
Vandekerckhove O., Buck E.D., Wijngaerden E.V.: Lyme disease in Western Europe: an emerging problem? A systematic review. Acta Clin Belg 2021; 76(3): 244–252. doi: 10.1080/17843286.2019.1694293.
Enkelmann J., Bohmer M., Patrierle V. i in.: Incidence of noti- fied Lyme borreliosis in Germany, 20132017. Sci Rep 2018; 8(1): 14976. doi: 10.1038/s41598018331360.
Septfons A., Goronflot T., Jaulhac B.: Epidemiology of Lyme borreliosis through two surveillance systems: the national Sentinelles GP network and the national hospital discharge database, France, 2005 to 2016. Euro Surveill 2019; 24(11): 1800134. doi: 10.2807/15607917.ES.2019.24.11.1800134.
Cairns V., Wallenhorst C., Rietbrock S. i in.: Incidence of Lyme disease in the UK: a populationbased cohort study. BMJ 2019; 9(7): e025916. doi: 10.1136/bmjopen2018025916.
Vigfusson H.B., Hardarson H.S., Ludviksson B.R.: Lyme disease in Iceland – epidemiology from 2011 to 2015 [Icelandic]. Laeknabladid 2019; 105(2): 63–70. doi: 10.17992/ lbl.2019.02.215.
Stanek G., Strle F.: Lyme Disease – European perspective. Infect Dis Clin North Am 2008; 22(2): 327–339. doi: 10.1016/j.idc.2008.01.001.
Stanek G., Wormser G.P., Gray J. i in.: Lyme borreliosis. Lancet 2012; 379: 461–473. doi: 10.1016/S01406736 (11)601037.
National Guideline Centre (UK): Lyme disease: diagnosis and management. National Institute for Health and Care Excellence (NICE). Londyn: Clinical Guidelines nr 95; 2018. http://www.ncbi.nlm.nih.gov/books/NBK542111/ (dostęp: 26.02.2025).
Murray T.S., Shapiro E.D.: Lyme Disease. Clin Lab Med, 2010; 30(1): 311–328. doi: 10.1016 /j.cll.2010.01.003.
Cardenasde la Garza J.A., De la CruzValadez E., Ocam- poCandiani J. i in.: Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis 2019; 38(2): 201–208. doi: 10.1007/s1009601834171.
Arvikar S.L., Steere A.C.: Diagnosis and treatment of Lyme arthritis, Infect Dis Clin North Am 2015; 29(2): 269–280. doi: 10.1016/j.idc. 2015.02.004.
Maraspin V., Klevisar M.N., RuzicSabljic E. i in.: Borrelial lymphocytoma in adult patients. Clin Infect Dis 2016; 63(7): 914–921. doi: 10.1093/cid/ciw417.
GarciaMonco J.C., Benach J.L.: Lyme neuroborreliosis: clinical outcomes, controversy, pathogenesis, and polymicrobial infections. Ann Neurol 2019; 85(1): 21–31. doi: 10.1002/ ana.25389.
Cooper L., BranaganHarris M., Tuson R. i in.: Lyme disease and Bell’s palsy: An epidemiological study of diagnosis and risk in England. Br J Gen Pract 2017; 67(658): e329–e335. doi: 10.3399/bjgp17X690497.
Ryberg B.: Bannwarth’s syndrome (lymphocytic meningoradiculitis) in Sweden. Yale J Biol Med 1984; 57(4): 499–503.
Träisk F., Lindquist L.: Optic nerve involvement in Lyme disease. Curr Opin Ophthalmol 2012; 23(6): 485–490. doi: 10.1097/ICU.0b013e328358b1eb.
Gade A., Matin T., Rubenstein R. i in.: Acrodermatitis Chronica Atrophicans, 2021; StatPearls. http://www.ncbi.nlm.nih.gov/books/NBK563289/ (dostęp: 17.02.2025).
Weiss T., Zhu P., White H. i in.: Latent Lyme disease resulting in chronic arthritis and early career termination in a United States army officer. Mil Med 2019; 184(7–8): e368–e370. doi: 10.1093/milmed/usz026.
Miklossy J.: Chronic or late Lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis. Open Neurol J 2012; 6: 146–157. doi: 10.2174/ 1874205X 01206010146.
Rebman A.W., Aucott J.N.: Posttreatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med 2020; 7: 57. doi: 10.3389/fmed.2020.00057.
Smoleńska Z., Matyjasek A., Zdrojewski Z.: Borelioza – najnowsze rekomendacje w diagnostyce i leczeniu. Forum Reumatol 2016; 2(2): 58–64.
Semen P., Petersen J., Hinckley A.: Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR, 2019; 68(32): 703. doi: 10.15585/ mmwr.mm6832a4.
TalagrandReboul E., Raffetin A., Zachary P. i in.: Immunoserological diagnosis of human borrelioses: current knowledge and perspectives. Front Cell Infect Microbiol 2020; 10: 241. doi: 10.3389/fcimb.2020.00241.
De Martino S.J., Sordet Ch., Piemont Y. i in.: Enhanced culture of Borrelia garinii and Borrelia afzelii strains on a solid BSKbased medium in anaerobic conditions. Res Microbiol 2006; 157(8): 726–729. doi: 10.1016/j.resmic.2006.05.002.
Veinović G., RuzicSabljic E., Strle F. i in.: Comparison of growth of Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto at five different temperatures. PloS One 2016; 11(6): e0157706. doi: 10.1371/journal.pone.0157706.
Pancewicz S.A., Garlicki A.M., MoniuszkoMalinowska A. i in.: Diagnostyka i leczenie chorób przenoszonych przez kleszcze. Rekomendacje Polskiego Towarzystwa Epidemiologów i Lekarzy Chorób Zakaźnych. Przegl Epidemiol 2015; 69: 421428.
Poland G.A., Jacobson R.M.: The prevention of Lyme disease with vaccine. Vaccine 2001; 19(17–19): 2303–2308. doi: 10.1016/s0264410x(00)00520x.
KallioKokko H., Uzcategui N., Vapalahti O. i in.: Viral zoonoses in Europe. FEMS Microbiol Rev 2005; 29(5): 1051–1077. doi: 10.1016/j.femsre.2005.04.012.
Wengler G., Wengler G., Gross H.J.: Studies on virusspecific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses. Virology 1978; 89(2): 423–437. doi: 10.1016/00426822(78)90185x.
Ecker M., Allison S.L., Meixner T. i in.: Sequence analysis and genetic classification of tickborne encephalitis viruses from Europe and Asia. J Gen Virol 1999; 80: 179–185. doi: 10.1099/00221317801179.
Heinz F.X.: Molecular aspects of TBE virus research. Vaccine 2003; 21(1): 3–10. doi: 10.1016/s0264410x (02)008204.
Siński E., WelcFalęciak R.: Ryzyko zakażeń przenoszonych przez kleszcze w ekosystemach leśnych Polski. Zarządzanie Ochroną Przyrody w Lasach 2012; 6: 96–111.
Lindquist L., Vapalahti O.: Tickborne encephalitis. Lancet 2008; 371(9627): 1861–1871. doi: 10.1016/S0140 6736(08)608004.
Offerdahl D.K., Clancy, N.G., Bloom M.E.: Stability of a tickborne Flavivirus in milk. Front. Bioeng Biotechnol 2016; 4(40): 1–6. doi: 10.3389/fbioe.2016.00040.
AvšičZupanc T., Poljak M., Maticic M.: Laboratory acquired tickborne meningoencephalitis: characterization of virus strains. Clin Diagn Virol 1995; 4: 51–59. doi: 10.1016/0928 0197 (94)00062y.
Fiecek B., Matławska M., Gołąb E. i in.: Risk of transmission of tickborne diseases by blood transfusion. Postępy Mikrobiol 2020; 59 (2): 129–137. doi: 10.21307/PM2020.59.2.010.
Siuda K.: Kleszcze Polski (Acari: Ixodida). Cz. 2. Systematyka i rozmieszczenie. Monografie Parazytologiczne. Warszawa: Polskie Towarzystwo Parazytologiczne; 1993. 1–375.
Drelich A., Kruszyński P., Wąsik T.J.: Etiopatogeneza kleszczowego zapalenia mózgu (KZM). Ann Acad Med Siles 2012; 66(6): 4–56.
ChitimiaDobler L., Lemhöfer G., Król N. i in.: Repeated isolation of tickborne encephalitis virus from adult Dermacentor reticulatus ticks in an endemic area in Germany. Parasites Vectors 2019; 12: 90. doi: 10.1186/s1307101933466.
Hasle G. Transport of ixodid ticks and tickborne pathogens by migratory birds. Front Cell Infect Microbiol 2013; 3: 48. doi:10.3389/fcimb.2013.00048.
Bušová, A., Dorko E., Feketeová E. i in.: Serostatus and risk factors of tickborne encephalitis. Cent Eur J Public Health, 2018; 26 (Suppl.): S56–S60. doi: 10.2110/cejph.a5289.
Kilpatrick AM., Randolph S.E.: Drivers, dynamics, and control of emerging vectorborne zoonotic diseases. Lancet 2012; 380 (9857): 1946–1955. doi: 10.1016/S0140 6736(12)611519.
Stefanoff P., Rubikowska B., Bratkowski J. i in.: A predictive model has identified tickborne encephalitis highrisk areas in regions where no cases were reported previously, Poland, 1999–2012. Int J Environ Res Public Health 2018; 15(4): 677. doi: 10.3390/ijerph15040677.
Stefanoff P., ZielickaHardy A., Hlebowicz M. i in.: New ende- mic foci of tickborne encephalitis (TBE) identified in districts where testing for TBE was not available before 2009 in Po- land. Parasit Vectors 2013; 6: 180. doi: 10.1186/17563305 6-180.
Zajkowska, J., Moniuszko A., Czupryna P. i in.: Chorea and tickborne encephalitis, Poland. Emerg Infect Dis 2013; 19(9): 1544–1545. doi: 10.3201/eid1909.130804.
European Centre for Disease Prevention and Control. Tic-kborne encephalitis. In: ECDC. Annual epidemiological report for 2016. Stockholm: ECDC; 2018. https://www.ecdc. europa.eu/en/publicationsdata/tickborneencephalitisan-nualepidemiologicalreport2016. Review of Medical Practice, 2025; Vol. XXXI, No. 262
European Centre for Disease Prevention and Control. Tick-borne encephalitis. In: ECDC. Annual epidemiological report for 2018. Stockholm: ECDC; 2019. https://www.ecdc.europa.eu/en/publicationsdata/tickborneencephalitisan-nualepidemiologicalreport2018.
European Centre for Disease Prevention and Control. Tick-borne encephalitis. In: ECDC. Annual epidemiological report for 2019. Stockholm: ECDC; 2021. https://www.ecdc.europa.eu/en/publicationsdata/tickborneencephalitisan-nualepidemiologicalreport2019.
Czarkowski M.P., Cielebąk E., StaszewskaJakubik E. i in.: Choroby zakaźne i zatrucia w Polsce w 2014 roku. Warszawa: Narodowy Instytut Zdrowia Publicznego Państwowy Zakład Higieny, Zakład Epidemiologii, Główny Inspektorat Sani- tarny, Departament Zapobiegania oraz Zwalczania Zakażeń i Chorób Zakaźnych u Ludzi; 2015. 1–165.
Czarkowski M.P., Cielebąk E., StaszewskaJakubik E. i in.: Choroby zakaźne i zatrucia w Polsce w 2015 roku. Warszawa: Narodowy Instytut Zdrowia Publicznego Państwowy Za- kład Higieny, Zakład Epidemiologii, Główny Inspektorat Sanitarny, Departament Zapobiegania oraz Zwalczania Zakażeń i Chorób Zakaźnych u Ludzi; 2016. 1–166.
Czarkowski M.P., Cielebąk E., StaszewskaJakubik E. i in.: Choroby zakaźne i zatrucia w Polsce w 2016 roku. Warszawa: Narodowy Instytut Zdrowia Publicznego Państwowy Za- kład Higieny, Zakład Epidemiologii, Główny Inspektorat Sanitarny, Departament Zapobiegania oraz Zwalczania Zakażeń i Chorób Zakaźnych u Ludzi; 2017. 1–166.
Czarkowski M.P., Cielebąk E., StaszewskaJakubik E. i in.: Choroby zakaźne i zatrucia w Polsce w 2017 roku. Warszawa: Narodowy Instytut Zdrowia Publicznego Państwowy Zakład Higieny, Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Główny Inspektorat Sanitarny, Departament Przeciwepidemiczny i Ochrony Sanitarnej Granic; 2018. 1–168.
Czarkowski M.P., Cielebąk E., Kondej B. i in.: Choroby zakaźne i zatrucia w Polsce w 2018 roku. Warszawa: Narodowy Instytut Zdrowia Publicznego Państwowy Zakład Higieny, Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Główny Inspektorat Sanitarny, Departament Przeciwepidemiczny i Ochrony Sanitarnej Granic; 2019. 1–168.
Czarkowski M.P., Niewęgłowska A., SzmulikMisiurek K. i in.: Choroby zakaźne i zatrucia w Polsce w 2019 roku. War- szawa: Narodowy Instytut Zdrowia Publicznego Państwowy Zakład Higieny, Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Główny Inspektorat Sanitarny, Departament Przeciwepidemiczny i Ochrony Sanitarnej Granic; 2020. 1–168.
Bojkiewicz E., Toczykowski K., Sulik A.: Tickborne encephalitis – a review of current epidemiology, clinical symptoms, management, and prevention. Przegl Epidemiol 2020; 74(2): 316–325. doi: 10.32394/pe.74.24.
Blaškovič D., Pučekova G., Kubínyi L. i in.: An epidemiological study of tickborne encephalitis in the Tribeč region: 195363. Bull World Health Organ 1967; 36(Suppl. 1): 89–95. PMID: 5298547.
Honig V., Carolan H.E., Vavruskova Z. i in.: Broadrange survey of vectorborne pathogens and tick host identification of Ixodes ricinus from Southern Czech Republic. FEMS Microbiol Ecol 2017; 93: fix129.
Laursen K., Knudsen J.D.: Tickborne encephalitis: A retrospective study of clinical cases in Bornholm, Denmark. Scand J Infect Dis 2003; 35(5): 354–357. doi: 10.1080/003655 40310005305.
Süss, J.: Tickborne encephalitis in Europe and beyond – the epidemiological situation as of 2007. Euro Surveill 2008; 13(26): 18916. doi: 10.2807/ese.13.26.18916en.
Dobler G., Zöller G., Poponnikova T. i in.: Tickborne encephalitis virus in a highly endemic area in Kemerovo (western Siberia, Russia). Int J Med Microbiol 2008; 298: 94–101.
Krotkova E.N., Babaeva I.V., Bogutskiy M. i in.: Epidemiological and clinical features of tickborne encephalitis in northwestern region of Belarus. Przegl Epidemiol 2016; 70(3): 436–443.
Špitalská E., Boldisova E., Stefanidesova K. i in.: Pathogenic microorganisms in ticks removed from Slovakian residents over the years 2008–2018. Ticks Tick Borne Dis 2021; 12(2): 101626. doi: 10.1016/j.ttbdis.2020.101626.
Human Animal Infections Risk Surveillance Group. HAIRS risk assessment: tickborne encephalitis. Qualitative assess- ment of the risk that tickborne encephalitis presents to the UK population. London: Public Health England; 2019. https://www.gov.uk/government/publications/ hairsriskassessmenttickborneencephalitis.
Egyed L., Élő P., SréterLancz Z. i in.: Seasonal activity and tickborne pathogen infection rates of Ixodes ricinus ticks in Hungary. Ticks Tick Borne Dis 2012; 3(2): 90–94. doi: 10.1016/j.ttbdis.2012.01.002.
Kaiser R.: The clinical and epidemiological profile of tickborne encephalitis in Southern Germany 1994–98: A Prospective Study of 656 Patients. Brain 1999; 122(11): 2067–2078. doi: 10.1093/brain/122.11.2067.
Mickienė A., Laiškonis A., Günther G. i in.: Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and longterm prognosis. Clin Infect Dis 2002; 35(6): 650–658. doi: 10.1086/342059.
Bogovic P., LotricFurlan S., Strle F.: What tickborne encephalitis may look like: clinical signs and symptoms. Travel Med Infect Dis 2010; 8: 246–250. doi: 10.1016/j.tmaid.2010.05.011.
Kaiser R.: Tickborne encephalitis. Infect Dis Clin North Am 2008; 22(3): 561–575. doi: 10.1016/j.idc.2008.03.013.
Mansfield K.L., Johnson N., Phipps L.P. i in.: Tickborne encephalitis virus – a review of an emerging zoonosis. J Gen Virol 2009; 90(Pt 8): 1781–1794. doi: 10.1099/vir.0.0114370.
Herzig R., Patt C.M., Prokes T.: An uncommon severe clinical course of European tickborne encephalitis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002; 146(2): 63–67. doi: 10.5507/bp.2002.013.
Diaz J.H.: Ticks, including tick paralysis. In: Mandell G.L., Bennrtt J.E. Dolin R. (eds.): Principles and Practice of Infec- tious Diseases. Elsevier 2014: 3266–3279.
Pfeffer M., Dobler G.: Tickborne encephalitis virus in dogs – is this an issue? Parasit Vectors 2011; 4: 59. doi: 10.1186/17563305459.
Litzba N., Zelená H., Kreil T.R. i in.: Evaluation of different serological diagnostic methods for tickborne encephalitis virus: enzymelinked immunosorbent, immunofluorescence, and neutralization assay. Vector Borne Zoonotic Dis 2014; 14(2): 149–159. doi: 10.1089/vbz.2012.1287.
Albinsson B., Jääskeläinen A.E., Värv K. i in.: Multilaboratory evaluation of ReaScan TBE IgM Rapid Test 2016 to 2017. Euro Surveill 2020; 25(12). doi: 10. 2807/15607917.ES. 2020. 25.12.1900427.
Günther G., Haglund M., Lindquist L. i in.: Intrathecal IgM, IgA and IgG antibody response in tickborne encephalitis. Longterm followup related to clinical course and outcome. Clin Diagn Virol 1997; 8(1): 17–29. doi: 10.1016/S09280197 (97)002730.
Reusken C., Boonstra M., Rugebregt S. i in.: An evaluation of serological methods to diagnose tickborne encephalitis from serum and cerebrospinal fluid. J Clin Virol 2019; 120: 78–83. doi: 10.1016/j.jcv.2019.09.009.
Bogovic P., Strle F.: Tickborne encephalitis: A review of epidemiology, clinical characteristics, and management. World J Clin Cases 2015; 3(5): 430–441. doi: 10.12998/wjcc. v3.i5.430.
Dörrbecker B., Dobler G., Spiegel M. i in.: Tickborne encephalitis virus and the immune response of the mammalian host. Travel Med Infect Dis 2010; 8: 213–222. doi: 10.1016 /j.tmaid.2010.05.010.
Brouqui P., Bacellar F., Baranton G. i in.: Guidelines for the diagnosis of tickborne bacterial diseases in Europe. Clin Microbiol Infect 2004; 10(12): 1108–1132. doi: 10.1111/j. 14690691.2004.01019.x.
Hayasaka D., Aoki K., Morita K.: Development of simple and rapid assay to detect viral RNA of tickborne encephalitis vi- rus by reverse transcriptionloopmediated isothermal amplification. Virol J 2013; 10: 68. doi: 10.1186/1743422X1068.
Holzmann H.: Diagnosis of tickborne encephalitis. Vaccine 2003; 21: S36–S40. doi: 10.1016/S0264410X (02)008198.
Dumpis U., Crook D., Oksi J.: Tickborne encephalitis. Clin Infect Dis 1999; 28(4): 882–890. doi: 10.1086/515195.
Petri E., Gniel D., Zent O. Tickborne encephalitis (TBE) trends in epidemiology and current and future management. Travel Med Infect Dis 2010; 8(4): 233–245. doi: 10.1016/j.tmaid.2010.08.001.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2025 Review of Medical Practice